These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 27389594)

  • 1. Genetic Landscape of Sporadic Unilateral Adrenocortical Adenomas Without PRKACA p.Leu206Arg Mutation.
    Ronchi CL; Di Dalmazi G; Faillot S; Sbiera S; Assié G; Weigand I; Calebiro D; Schwarzmayr T; Appenzeller S; Rubin B; Waldmann J; Scaroni C; Bartsch DK; Mantero F; Mannelli M; Kastelan D; Chiodini I; Bertherat J; Reincke M; Strom TM; Fassnacht M; Beuschlein F;
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3526-38. PubMed ID: 27389594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: a single-center study of 60 cases.
    Thiel A; Reis AC; Haase M; Goh G; Schott M; Willenberg HS; Scholl UI
    Eur J Endocrinol; 2015 Jun; 172(6):677-85. PubMed ID: 25750087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRKACA Somatic Mutations Are Rare Findings in Aldosterone-Producing Adenomas.
    Rhayem Y; Perez-Rivas LG; Dietz A; Bathon K; Gebhard C; Riester A; Mauracher B; Gomez-Sanchez C; Eisenhofer G; Schwarzmayr T; Calebiro D; Strom TM; Reincke M; Beuschlein F
    J Clin Endocrinol Metab; 2016 Aug; 101(8):3010-7. PubMed ID: 27270477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas.
    Ronchi CL; Peverelli E; Herterich S; Weigand I; Mantovani G; Schwarzmayr T; Sbiera S; Allolio B; Honegger J; Appenzeller S; Lania AG; Reincke M; Calebiro D; Spada A; Buchfelder M; Flitsch J; Strom TM; Fassnacht M
    Eur J Endocrinol; 2016 Mar; 174(3):363-72. PubMed ID: 26701869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing's syndrome: a European multicentric study.
    Di Dalmazi G; Kisker C; Calebiro D; Mannelli M; Canu L; Arnaldi G; Quinkler M; Rayes N; Tabarin A; Laure Jullié M; Mantero F; Rubin B; Waldmann J; Bartsch DK; Pasquali R; Lohse M; Allolio B; Fassnacht M; Beuschlein F; Reincke M
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E2093-100. PubMed ID: 25057884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors.
    Gaujoux S; Tissier F; Groussin L; Libé R; Ragazzon B; Launay P; Audebourg A; Dousset B; Bertagna X; Bertherat J
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4135-40. PubMed ID: 18647815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activating hotspot L205R mutation in PRKACA and adrenal Cushing's syndrome.
    Cao Y; He M; Gao Z; Peng Y; Li Y; Li L; Zhou W; Li X; Zhong X; Lei Y; Su T; Wang H; Jiang Y; Yang L; Wei W; Yang X; Jiang X; Liu L; He J; Ye J; Wei Q; Li Y; Wang W; Wang J; Ning G
    Science; 2014 May; 344(6186):913-7. PubMed ID: 24700472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Causes of Functional Adrenocortical Adenomas.
    Zennaro MC; Boulkroun S; Fernandes-Rosa F
    Endocr Rev; 2017 Dec; 38(6):516-537. PubMed ID: 28973103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA Sequencing and Somatic Mutation Status of Adrenocortical Tumors: Novel Pathogenetic Insights.
    Di Dalmazi G; Altieri B; Scholz C; Sbiera S; Luconi M; Waldman J; Kastelan D; Ceccato F; Chiodini I; Arnaldi G; Riester A; Osswald A; Beuschlein F; Sauer S; Fassnacht M; Appenzeller S; Ronchi CL
    J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32875319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt/β-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors.
    Bonnet S; Gaujoux S; Launay P; Baudry C; Chokri I; Ragazzon B; Libé R; René-Corail F; Audebourg A; Vacher-Lavenu MC; Groussin L; Bertagna X; Dousset B; Bertherat J; Tissier F
    J Clin Endocrinol Metab; 2011 Feb; 96(2):E419-26. PubMed ID: 21084400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cAMP signaling in cortisol-producing adrenal adenoma.
    Calebiro D; Di Dalmazi G; Bathon K; Ronchi CL; Beuschlein F
    Eur J Endocrinol; 2015 Oct; 173(4):M99-106. PubMed ID: 26139209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double adrenocortical adenomas harboring independent KCNJ5 and PRKACA somatic mutations.
    Nanba K; Omata K; Tomlins SA; Giordano TJ; Hammer GD; Rainey WE; Else T
    Eur J Endocrinol; 2016 Aug; 175(2):K1-6. PubMed ID: 27165862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroidogenic Acute Regulatory Protein Overexpression Correlates with Protein Kinase A Activation in Adrenocortical Adenoma.
    Zhou W; Wu L; Xie J; Su T; Jiang L; Jiang Y; Cao Y; Liu J; Ning G; Wang W
    PLoS One; 2016; 11(9):e0162606. PubMed ID: 27606678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of PRKACA mutations in Chinese patients with adrenal lesions: a single-centre study.
    Li X; Wang B; Tang L; Lang B; Zhang Y; Zhang F; Chen L; Ouyang J; Zhang X
    Clin Endocrinol (Oxf); 2016 Dec; 85(6):954-961. PubMed ID: 27296931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome.
    Sato Y; Maekawa S; Ishii R; Sanada M; Morikawa T; Shiraishi Y; Yoshida K; Nagata Y; Sato-Otsubo A; Yoshizato T; Suzuki H; Shiozawa Y; Kataoka K; Kon A; Aoki K; Chiba K; Tanaka H; Kume H; Miyano S; Fukayama M; Nureki O; Homma Y; Ogawa S
    Science; 2014 May; 344(6186):917-20. PubMed ID: 24855271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Mutational Analysis of Cortisol-Producing Adenomas.
    Rege J; Hoxie J; Liu CJ; Cash MN; Luther JM; Gellert L; Turcu AF; Else T; Giordano TJ; Udager AM; Rainey WE; Nanba K
    J Clin Endocrinol Metab; 2022 Jan; 107(2):e594-e603. PubMed ID: 34534321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare correlation of somatic PRKACA mutations with pregnancy-associated aldosterone- and cortisol-producing adenomas: a case report and literature review.
    Lin J; Li Y; Huang Z; Zhu Y; Li L; Yang H; Liang X; Qin Y; Zhou J; Xian J; Liu D; Lu D; Luo Z
    BMC Endocr Disord; 2024 Jul; 24(1):116. PubMed ID: 39010034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors.
    Goh G; Scholl UI; Healy JM; Choi M; Prasad ML; Nelson-Williams C; Kunstman JW; Korah R; Suttorp AC; Dietrich D; Haase M; Willenberg HS; Stålberg P; Hellman P; Akerström G; Björklund P; Carling T; Lifton RP
    Nat Genet; 2014 Jun; 46(6):613-7. PubMed ID: 24747643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Genetic and Genomic Alterations in Cushing's Syndrome and Primary Aldosteronism.
    Kamilaris CDC; Stratakis CA; Hannah-Shmouni F
    Front Endocrinol (Lausanne); 2021; 12():632543. PubMed ID: 33776926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of benign unilateral adrenocortical tumors: focus on cAMP/PKA pathway.
    Weigand I
    Minerva Endocrinol; 2019 Mar; 44(1):25-32. PubMed ID: 29963826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.